Arkolith/Insider Trading/PBSV/Form 4

Wiesen Irving L

DirectorPharma-Bio Serv, Inc. (PBSV) · full profile →Form 4 · filed Mar 28, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 24, 2023Tax withholding(F)17K$1.17$20K47K
Mar 24, 2023Option exercise(M)20K$1.00$20K64K
Mar 24, 2023Tax withholding(F)13K$1.17$15K54K
Mar 24, 2023Option exercise(M)20K$0.76$15K67K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 24, 2023Option exercise(M)20K—$00
Mar 24, 2023Option exercise(M)20K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-23-003751) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML